- Infection prevention product manufacturer Tristel said that MobileODT, of which it held a 2.13% strategic equity stake, had successfully completed the first closing of a $9.75m second-round institutional fund raising.

The funding had been led by OrbiMed Israel Partners and would provide MobileODTwith further growth capital.

Whilst Tristel did not participate in this latest funding round, it said it had invested $0.91m in MobileODT since June 2017.

Story provided by